Iversol 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. This medication is indicated for the treatment of strongyloidiasis, onchocerciasis, and other parasitic infestations caused by susceptible nematodes and arthropods. Iversol 12 is administered orally, with dosage and duration tailored to the specific infection and patient characteristics. It is generally well tolerated; however, adverse effects may include dizziness, nausea, diarrhea, and mild skin reactions. Caution is advised in patients with impaired liver function or those with a history of hypersensitivity to ivermectin. It is contraindicated in children weighing less than 15 kg and during pregnancy due to insufficient safety data. Iversol 12 should be used under medical supervision, ensuring appropriate diagnosis and monitoring for therapeutic efficacy and potential side effects. Proper adherence to prescribed dosage enhances treatment outcomes and minimizes the risk of resistance development.